Concord Wealth Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Concord Wealth Partners's ELV Position: Q2 2026 in Review
Concord Wealth Partners opened a new position in Elevance Health (ELV) in Q2 2026: 87 shares worth $33.6K. The stake represents ﹤0.01% of the portfolio and ranks #417 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in ELV as recently as Q4 2025.
Concord Wealth Partners first reported a position in ELV in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.27M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Concord Wealth Partners held 87 shares of Elevance Health worth $33.6K as of Q2 2026.
- Elevance Health was a new Concord Wealth Partners position in Q2 2026.
- Elevance Health made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #417 holding.
- Concord Wealth Partners first reported a position in Elevance Health in Q4 2020 and has held it in 22 quarters since.
- Concord Wealth Partners's Elevance Health position peaked at $1.27M in Q3 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.